Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Algernon Health Inc
(OP:
AGNPF
)
0.0363
UNCHANGED
Streaming Delayed Price
Updated: 3:30 PM EST, Feb 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0363
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0363
Today's Range
0.0363 - 0.0363
52wk Range
0.0340 - 0.0900
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
↗
April 17, 2024
Via
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
↗
April 03, 2024
Via
Benzinga
Performance
YTD
-21.4%
-21.4%
1 Month
-6.9%
-6.9%
3 Month
-36.0%
-36.0%
6 Month
-30.3%
-30.3%
1 Year
-57.3%
-57.3%
More News
Read More
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
↗
August 14, 2023
Via
Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
↗
August 08, 2023
Via
Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
↗
July 18, 2022
Via
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
↗
June 05, 2023
Via
Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
↗
April 04, 2023
Via
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
↗
April 04, 2023
Via
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
↗
March 07, 2023
Via
Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
↗
March 03, 2023
Via
Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
↗
March 01, 2023
Via
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
↗
February 27, 2023
Via
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
↗
February 21, 2023
Via
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
↗
February 21, 2023
Via
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
↗
February 16, 2023
Via
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
↗
January 18, 2023
Via
Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
↗
January 03, 2023
Via
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
↗
December 15, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
↗
November 21, 2022
Via
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
↗
November 16, 2022
Via
Benzinga
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
November 08, 2022
Via
Newsfile
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
↗
October 24, 2022
Via
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
↗
September 12, 2022
Via
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
↗
September 08, 2022
Via
Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
↗
August 23, 2022
Via
Benzinga
Frequently Asked Questions
Is Algernon Health Inc publicly traded?
Yes, Algernon Health Inc is publicly traded.
What exchange does Algernon Health Inc trade on?
Algernon Health Inc trades on the OTC Traded
What is the ticker symbol for Algernon Health Inc?
The ticker symbol for Algernon Health Inc is AGNPF on the OTC Traded
What is the current price of Algernon Health Inc?
The current price of Algernon Health Inc is 0.0363
When was Algernon Health Inc last traded?
The last trade of Algernon Health Inc was at 02/05/26 03:30 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today